Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product Calcipressin 1 (or RCAN1) in disease

[1]  Andre Levchenko,et al.  GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. , 2004, Genes & development.

[2]  B. Siesjö,et al.  The density and distribution of ischemic brain injury in the rat following 2–10 min of forebrain ischemia , 2004, Acta Neuropathologica.

[3]  K. Davies,et al.  Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein. , 2003, Free radical biology & medicine.

[4]  X. Estivill,et al.  Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life. , 2003, The Biochemical journal.

[5]  M. Zaidi,et al.  Mitochondria to nucleus stress signaling , 2003, Journal of Cell Biology.

[6]  Rick B. Vega,et al.  Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Abboud,et al.  Calcineurin is activated in diabetes and is required for glomerular hypertrophy and ECM accumulation. , 2003, American journal of physiology. Renal physiology.

[8]  F. Henrique-Silva,et al.  Mutational analyses of the signals involved in the subcellular location of DSCR1 , 2002, BMC Cell Biology.

[9]  P. Knapp,et al.  FK506 Treatment Inhibits Caspase-3 Activation and Promotes Oligodendroglial Survival Following Traumatic Spinal Cord Injury , 2002, Experimental Neurology.

[10]  Rick B. Vega,et al.  Multiple Domains of MCIP1 Contribute to Inhibition of Calcineurin Activity* , 2002, The Journal of Biological Chemistry.

[11]  G. Perkins,et al.  Differential Neuroprotection by Cyclosporin A and FK506 Following Ischemia Corresponds with Differing Abilities to Inhibit Calcineurin and the Mitochondrial Permeability Transition , 2002, Neurobiology of Disease.

[12]  J. Marier,et al.  Cyclosporin A in blood and brain tissue following intra-carotid injections in normal and stroke-induced rats , 2002, Brain Research.

[13]  K. Davies,et al.  The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium‐mediated stress damage, including transient oxidative stress , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  T. Shimahara,et al.  Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus , 2002, Neurobiology of Learning and Memory.

[15]  N. Reynolds,et al.  Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. , 2002, The Journal of investigative dermatology.

[16]  R. Weiss,et al.  Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy , 2002, The Journal of Biological Chemistry.

[17]  J. Molkentin,et al.  Impaired cardiac hypertrophic response in Calcineurin Aβ-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Sung-Hwan Park,et al.  Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. , 2002, Arthritis and rheumatism.

[19]  H. Abboud,et al.  Insulin-like Growth Factor-I Induces Renal Cell Hypertrophy via a Calcineurin-dependent Mechanism* , 2001, The Journal of Biological Chemistry.

[20]  Rick B. Vega,et al.  Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Hajjar,et al.  Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  X. Estivill,et al.  Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis , 2001, Mechanisms of Development.

[23]  B. Siesjö,et al.  Effects of intracarotid arterial injection of cyclosporin A and spontaneous hypothermia on brain damage incurred after a long period of global ischemia , 2001, Brain Research.

[24]  T. Shike,et al.  Animal models. , 2001, Contributions to nephrology.

[25]  K. Davies,et al.  The essential role of calcium in induction of the DSCR1 (ADAPT78) gene , 2001, BioFactors.

[26]  E. Olson,et al.  Independent Signals Control Expression of the Calcineurin Inhibitory Proteins MCIP1 and MCIP2 in Striated Muscles , 2000, Circulation research.

[27]  P. Strippoli,et al.  The murine DSCR1-like (Down syndrome candidate region 1) gene family: conserved synteny with the human orthologous genes. , 2000, Gene.

[28]  M. Hori,et al.  Calcineurin Inhibitor Attenuates Left Ventricular Hypertrophy, Leading to Prevention of Heart Failure in Hypertensive Rats , 2000, Circulation.

[29]  B. Siesjö,et al.  Cyclosporin A Enhances Survival, Ameliorates Brain Damage, and Prevents Secondary Mitochondrial Dysfunction after a 30-Minute Period of Transient Cerebral Ischemia , 2000, Experimental Neurology.

[30]  R. Powell,et al.  Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma. , 2000, Rheumatology.

[31]  J. Heitman,et al.  Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans , 2000, The EMBO journal.

[32]  D. Crawford,et al.  adapt78 protects cells against stress damage and suppresses cell growth. , 2000, Archives of biochemistry and biophysics.

[33]  K. Cunningham,et al.  A conserved family of calcineurin regulators. , 2000, Genes & development.

[34]  X. Estivill,et al.  DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. , 2000, Human molecular genetics.

[35]  M. Hattori,et al.  The DNA sequence of human chromosome 21 , 2000, Nature.

[36]  E. Olson,et al.  MEF2 responds to multiple calcium‐regulated signals in the control of skeletal muscle fiber type , 2000, The EMBO journal.

[37]  Rick B. Vega,et al.  A Protein Encoded within the Down Syndrome Critical Region Is Enriched in Striated Muscles and Inhibits Calcineurin Signaling* , 2000, The Journal of Biological Chemistry.

[38]  P. Strippoli,et al.  A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2). , 2000, Genomics.

[39]  J. Molkentin,et al.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Mertz,et al.  Calcineurin: form and function. , 2000, Physiological reviews.

[41]  A. Asai,et al.  High Level Calcineurin Activity Predisposes Neuronal Cells to Apoptosis* , 1999, The Journal of Biological Chemistry.

[42]  Z. Mao,et al.  Calcineurin Enhances MEF2 DNA Binding Activity in Calcium-dependent Survival of Cerebellar Granule Neurons* , 1999, The Journal of Biological Chemistry.

[43]  B. Siesjö,et al.  Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia , 1999, Brain Research.

[44]  A. Musarò,et al.  IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1 , 1999, Nature.

[45]  A. Petronis.  Alzheimer's Disease and Down Syndrome: From Meiosis to Dementia , 1999, Experimental Neurology.

[46]  K. Davies,et al.  adapt78, a stress-inducible mRNA, is related to the glucose-regulated protein family of genes. , 1999, Archives of biochemistry and biophysics.

[47]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[48]  T. Borg,et al.  Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. , 1999, Circulation research.

[49]  E. Olson,et al.  Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. , 1999, Circulation research.

[50]  M. Billingsley,et al.  Reduction of calcineurin activity in brain by antisense oligonucleotides leads to persistent phosphorylation of tau protein at Thr181 and Thr231. , 1999, Molecular pharmacology.

[51]  D. Choi,et al.  Ischemic Tolerance in Murine Cortical Cell Culture: Critical Role for NMDA Receptors , 1999, The Journal of Neuroscience.

[52]  M. Schwaninger,et al.  Characterization of a Novel Calcium Response Element in the Glucagon Gene* , 1999, The Journal of Biological Chemistry.

[53]  M. Rudin,et al.  Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. , 1999, The Journal of pharmacology and experimental therapeutics.

[54]  J. Bach,et al.  The contribution of cyclosporine A to the understanding and treatment of autoimmune diseases. , 1999, Transplantation proceedings.

[55]  M. Rudin,et al.  Calcineurin Inhibitors FK 506 and SDZ ASM 981 Alleviate the Outcome of Focal Cerebral Ischemic / Reperfusion Injury , 1999 .

[56]  M. Dimitrijević,et al.  Cyclosporine in the treatment of autoimmune disorders: a 10-year experience. , 1998, Transplantation proceedings.

[57]  Ping-An Li,et al.  Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat , 1998, Brain Research.

[58]  K. Arai,et al.  Signalling into the T-cell nucleus: NFAT regulation. , 1998, Cellular signalling.

[59]  Mark A Sussman,et al.  Prevention of cardiac hypertrophy in mice by calcineurin inhibition. , 1998, Science.

[60]  W. Zhu,et al.  A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. , 1998, Genes & development.

[61]  G. Johnson,et al.  Calcineurin inhibition prevents calpain‐mediated proteolysis of tau in differentiated PC12 cells , 1998, Journal of neuroscience research.

[62]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[63]  X. Estivill,et al.  Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. , 1997, Genomics.

[64]  S. Butcher,et al.  Neuroprotective Actions of FK506 in Experimental Stroke: In Vivo Evidence against an Antiexcitotoxic Mechanism , 1997, The Journal of Neuroscience.

[65]  K. Davies,et al.  Hamster adapt78 mRNA is a Down syndrome critical region homologue that is inducible by oxidative stress. , 1997, Archives of biochemistry and biophysics.

[66]  J. Seidman,et al.  Cytoskeletal Changes in the Brains of Mice Lacking Calcineurin Aα , 1997, Journal of neurochemistry.

[67]  M. Pittelkow,et al.  Cyclosporine in the treatment of dermatologic disease: an update. , 1996, Mayo Clinic proceedings.

[68]  T. McKinsey,et al.  Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product , 1996, Molecular and cellular biology.

[69]  C. Epstein,et al.  Effects of Nitric Oxide Synthase Inhibition on Brain Infarction in SOD-1-Transgenic Mice following Transient Focal Cerebral Ischemia , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[70]  P. Greengard,et al.  Amyloid beta peptide formation in cell-free preparations. Regulation by protein kinase C, calmodulin, and calcineurin. , 1996, The Journal of biological chemistry.

[71]  T. Wieloch,et al.  The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain. , 1996, Acta physiologica Scandinavica.

[72]  John M. Lee,et al.  Reduction of Calcineurin Enzymatic Activity in Alzheimer's Disease: Correlation with Neuropathologic Changes , 1996, Journal of neuropathology and experimental neurology.

[73]  D. Söll,et al.  A mutation in protein phosphatase 2A regulatory subunit A affects auxin transport in Arabidopsis. , 1996, The EMBO journal.

[74]  X. Estivill,et al.  A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. , 1995, Human molecular genetics.

[75]  K. Davies,et al.  Transient adaptation of oxidative stress in mammalian cells. , 1995, Archives of biochemistry and biophysics.

[76]  E. A. O'neill,et al.  Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B. , 1994, The EMBO journal.

[77]  S. Snyder,et al.  Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[78]  B. Marino.  Congenital heart disease in patients with Down's syndrome: anatomic and genetic aspects. , 1993, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[79]  T. Starzl,et al.  Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. , 1992, Archives of dermatology.

[80]  T. Kuno,et al.  Distinct Cellular Expression of Calcineurin Aα and Aβ in Rat Brain , 1992 .

[81]  T. Kuno,et al.  Distinct cellular expression of calcineurin A alpha and A beta in rat brain. , 1992, Journal of neurochemistry.

[82]  C. Epstein,et al.  Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[83]  L. Notarangelo,et al.  Immunology of Down syndrome: a review. , 2005, American journal of medical genetics. Supplement.

[84]  K. Mikoshiba,et al.  ‘Ischemic tolerance’ phenomenon found in the brain , 1990, Brain Research.

[85]  J. Nadler,et al.  Selective neuronal death after transient forebrain ischemia in the mongolian gerbil: A silver impregnation study , 1988, Neuroscience.

[86]  J. Billings,et al.  Cyclosporine improves psoriasis in a double-blind study. , 1986, JAMA.

[87]  E. Miyamoto,et al.  The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay , 1986, Brain Research.

[88]  Takaaki Kirino,et al.  Delayed neuronal death in the gerbil hippocampus following ischemia , 1982, Brain Research.